. . . . . . . . . "Oxcarbazepine oral suspension is indicated for use as monotherapy or adjunctive therapy in the treatment of partial-onset seizures in adults and as monotherapy in the treatment of partial-onset seizures in pediatric patients aged 4 years and above, and as adjunctive therapy in pediatric patients aged 2 years and above with partial-onset seizures." . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" . "UTEeHwYfV6inHkcTx2niWTf7Ohg0EvKibWcmaNMj3Ihdt6p0yT4KiP1ugQM8N7TQQjuPVFGUpRv9fQOyBuq4cQK+AFZYnqJI21Klqou6PhLmHl9MnO4AbKImtxWzY85mKAUSBk1fu/Stn3+g8MzsxUK+trpMUv65C19FOkK6OQo=" . . "2021-04-03T11:32:11.095+02:00"^^ . . . . .